Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Pfizer Inc.    PFE

PFIZER INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Analyst Recommendations on PFIZER INC.
01/08PFIZER INC : Goldman Sachs gives a Neutral rating
MD
2020PFIZER INC : RBC remains Neutral
MD
2020PFIZER : RBC Capital Downgrades Pfizer to Sector Perform From Outperform, Adjust..
MT
2020PFIZER INC : Goldman Sachs gives a Neutral rating
MD
2020PFIZER INC : Goldman Sachs remains Neutral
MD
2020PFIZER : FDA Panel Endorses Covid-19 Vaccine -- 7th Update
DJ
2020PFIZER : FDA Panel Endorses Covid-19 Vaccine -- 6th Update
DJ
2020PFIZER : FDA Panel Endorses Covid-19 Vaccine -- 5th Update
DJ
2020PFIZER : FDA Advisory Panel Endorses Pfizer-BioNTech Covid-19 Vaccine -- 3rd Upd..
DJ
2020WALL STREET WEEK AHEAD : After blazing energy rally, investors check the fuel ga..
RE
2020Barclays Adjusts Pfizer PT to $37 From $33.18, Maintains Equal Weight Rating
MT
2020German bond yields dip before U.S. jobs data, but set for biggest weekly rise..
RE
2020Pfizer and BioNTech's Covid-19 Vaccine Wins U.K. Authorization -- 7th Update
DJ
2020PFIZER INC : Barclays sticks Neutral
MD
2020UK approves Pfizer-BioNTech COVID-19 vaccine in world first
RE
2020PFIZER INC : RBC gives a Buy rating
MD
2020PFIZER INC : Gets a Neutral rating from Goldman Sachs
MD
2020AstraZeneca Gears Up to Vaccinate the World Against Covid-19
DJ
2020AstraZeneca, Oxford Covid-19 Vaccine Up to 90% Effective in Late-Stage Trials..
DJ
2020Rand jumps despite ratings downgrade, EM stocks rally on vaccine hopes
RE
2020PFIZER, GILEAD, ROSS : What to Watch When the Stock Market Opens Today
DJ
2020Goldman Resumes Pfizer at Neutral With $40 Price Target
MT
2020MACY'S, NVIDIA, SIMON PROPERTY GROUP : What to Watch When the Stock Market Opens..
DJ
2020NVIDIA, SIMON PROPERTY GROUP, BNY ME : What to Watch When the Stock Market Opens..
DJ
2020Pfizer Says Covid Vaccine Is 95% Effective in Final Data, Will Seek Authoriza..
DJ
2020Pfizer's Covid-19 Vaccine 95% Effective in Final Results, Company to Seek App..
DJ
2020MODERNA : Rate cut bets melt as vaccines boost economy hopes
RE
2020Aramco Plans U.S. Dollar Bond to Plug Funding Gap -- Update
DJ
2020Bernstein Reinstates Pfizer at Market Perform with $42 Price Target
MT
2020Arcturus expects its COVID-19 vaccine to be ready by Q1 2021
RE
2020PFIZER : BioNTech Shares Hit 52-Week Highs on Covid-19 Vaccine Candidate News
DJ
2020PFIZER INC : JP Morgan reaffirms its Neutral rating
MD
2020PFIZER INC : Barclays remains Neutral
MD
2020PFIZER : BioNTech Shares Rise After Positive News for Covid-19 Vaccine Candidate
DJ
2020PFIZER INC : RBC reiterates its Buy rating
MD
2020PFIZER INC : Buy rating from RBC
MD
2020Exxon's Departure From Dow Highlights Market's Retreat From Energy Bets
DJ
2020Top FDA official says would resign if agency rubber-stamps an unproven COVID-..
RE
2020Top FDA official says would resign if agency rubber-stamps an unproven COVID-..
RE
2020U.S. FDA rejects BioMarin hemophilia A gene therapy, shares dive
RE
2020Moderna shares rise 11% on $1.5 billion U.S. contract for COVID-19 vaccine
RE
2020Biotech company CureVac aims to raise up to $245 million in U.S. IPO
RE
2020Biotech company CureVac aims to raise up to $245 million in U.S. IPO
RE
2020U.S. companies leap over low profit hurdle in coronavirus-hit quarter
RE
2020U.S. companies leap over low profit hurdle in coronavirus-hit quarter
RE
2020Pharma Companies Split on Coronavirus Vaccine Pricing Plans
DJ
2020PFIZER INC : RBC remains its Buy rating
MD
2020GSK's long-acting injection beats Truvada in HIV prevention trial
RE
2020Novartis predicts rising sales and minimal disruption from coronavirus
RE
2020PFIZER INC : JP Morgan remains Neutral
MD
2020PFIZER INC : Gets a Buy rating from RBC
MD
2019Bristol-Myers posts better-than-expected results, Opdivo growth slows
RE
2019PFIZER INC : JP Morgan gives a Neutral rating
MD
2019PFIZER INC : Upgraded to Neutral by DZ Bank
MD
2019PFIZER INC : UBS sticks Neutral
MD
2019PFIZER INC : JP Morgan gives a Neutral rating
MD
2019PFIZER INC : JP Morgan reiterates its Neutral rating
MD
2019PFIZER INC : JP Morgan reiterates its Neutral rating
MD
2019Eliquis, Orencia sales propel Bristol-Myers to strong second quarter
RE
2019GSK raises 2019 earnings expectations after standout quarter for Shingrix
RE
2019GSK raises 2019 earnings expectations after standout quarter for Shingrix
RE
2019GSK raises 2019 earnings expectations after standout quarter for Shingrix
RE
2019PFIZER INC : JP Morgan reaffirms its Neutral rating
MD
2019Gilead invests $5 billion to deepen ties with biotech Galapagos
RE
2019Gilead invests $5 billion to deepen ties with biotech Galapagos
RE
2019PFIZER INC : Receives a Buy rating from Goldman Sachs
MD
2019PFIZER INC : Credit Suisse reiterates its Buy rating
MD
2019PFIZER INC : JP Morgan remains Neutral
MD
2019PFIZER INC : Credit Suisse keeps its Buy rating
MD
2019PFIZER INC : JP Morgan sticks Neutral
MD
2019PFIZER INC : JP Morgan reiterates its Neutral rating
MD
2018GLOBAL MARKETS LIVE : Facebook, Pfizer, Bombardier, Nissan…
2018AstraZeneca sees years of growth as drug sales turn corner
RE
2018Pfizer to replace longtime CEO Read with veteran Bourla
RE
2018Pfizer to replace longtime CEO Read with veteran Bourla
RE
1  2Next
Upcoming event on PFIZER INC.